90-kDa S6 kinase is insufficient or not involved in the activation of glycogen synthase induced by insulin

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.316, Iss.2, 1996-12, pp. : 317-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes

By Eldar-Finkelman Hagit Kaidanovich Oksana

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 5, 2002-10 ,pp. : 555-561

Informa Healthcare

Access to resources Recommend Favorite

Role of Glycogen Synthase Kinase-3 in Insulin Resistance and Type 2 Diabetes

Current Drug Targets, Vol. 7, Iss. 11, 2006-01 ,pp. : 1435-1441

Bentham Science Publishers

Access to resources Recommend Favorite

Role of glycogen synthase kinase-3 in l-DOPA-induced neurotoxicity

By Koh Seong-Ho Kim Seung Hyun Kim Hee-Tae

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 11, 2009-11 ,pp. : 1359-1368

Informa Healthcare

Access to resources Recommend Favorite

Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment

By Eldar-Finkelman Hagit Ilouz Ronit

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1511-1519

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Glycogen Synthase Kinase-3 Reverses Tau Hyperphosphorylation Induced by Pin1 Down-Regulation

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 3, 2013-05 ,pp. : 436-443

Bentham Science Publishers

Access to resources Recommend Favorite